Viatris | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Adcock Ingram Holdings ZAR 5.54B 131.19M 2024-12
Celltrion KRW 17.14T 298.25B 2025-03
Cspc Pharmaceutical CNY 32.26B 2.59B 2024-12
Dianthus Therapeutics USD 303.08M 49.4M 2025-06
Divis Laboratories Ltd 149.69B 12.52B 2025-03
Kangmei Pharma CNY 7.73B 546.26M 2025-06
Knight Therapeutics CAD 773.91M 11.11M 2024-09
Laboratorios Farma EUR 574.72M 6.82M 2025-06
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 55.33M 9.6M 2024-12
Neuren Pharmaceuticals AUD 363.9M 144.75M 2024-12
Organigram Holdings CAD 385.5M 61.85M 2025-06
Pharma Mar EUR 201.53M 4.06M 2025-06
Qiagen NV USD 3.51B 97.61M 2025-06
Sartorius EUR 2.66B 51.3M 2025-06
Sino Biopharmaceutical CNY 31.96B 884.2M 2024-12
Tilray USD 3.47B 5.16M 2024-11
Viatris USD 15.57B 79.9M 2025-06
Zz Pientze Pharmaceu 14.65B 617.48M 2025-06


Viatris Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.